10x Genomics, Inc. · NASDAQ:TXG
Stuelpnagel John R received 8,829 10x Genomics, Inc. shares as an award (Form 4)
Traded Jun 4, 2026 · Filed Jun 8, 2026
On Jun 4, 2026, Stuelpnagel John R (Director) received 8,829 10x Genomics, Inc. shares as an award, leaving 368,436 shares. Filed Jun 8, 2026 (Form 4).
- Awarded
- 8,829 shares
- Holding after
- 368,436 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 4, 2026 | Class A Common Stock | Award | 8,829 | 368,436 | Direct |
Source
Related
- 10x Genomics, Inc.
- Stuelpnagel John R
- 10x Genomics, Inc. shareholders
- Form 4 · Stuelpnagel John R · Sep 8, 2026
- Form 4 · Stuelpnagel John R · Aug 13, 2026
- Schedule 13G/A · ARK Investment Management LLC · Oct 7, 2026
- Form 4 · Suliman Shehnaaz · Sep 24, 2026
- Form 4 · Saxonov Serge · Sep 24, 2026
- Form 4 · Taich Adam · Sep 11, 2026
- Schedule 13G · T. Rowe Price Associates Inc · Sep 8, 2026